| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/02/2004 | US20040171104 may be used in food related applications to improve flavor, such as baking; genetic engineering |
| 09/02/2004 | US20040171084 Screening compound libraries using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 09/02/2004 | US20040171018 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 09/02/2004 | US20040171012 Nucleic acid-associated proteins |
| 09/02/2004 | US20040171005 Codon-optimised nucleic acid coding for apoaequorin and uses thereof |
| 09/02/2004 | US20040171003 Using oligonucleotide probes to generate gene expression profile of tumor marker proteins for use in diagnosis of cell proliferative disorders |
| 09/02/2004 | US20040170989 Cellular gene targets for controlling cell growth |
| 09/02/2004 | US20040170974 for drug screening treatments for asthma/inflammatory disorders; genetic engineering; kits |
| 09/02/2004 | US20040170973 DNA encoding the human serine protease EOS |
| 09/02/2004 | US20040170972 comprises DNA vaccine, a recombinant vaccine, and a T cell epitope vaccine; includes use of serological diagnosis; genetic engineering |
| 09/02/2004 | US20040170970 Split- ubiquitin based reporter systems and methods of their use |
| 09/02/2004 | US20040170953 comprises using a phosphate buffer that specifically binds to hepatitis B virus; genetic engineering; kits |
| 09/02/2004 | US20040170653 recognised by CD8-positive cytotoxic T-lymphocytes as a peptide antigen and causes a CTL-induced lysis and/or apoptosis of tumor or leukemia cell; has the amino acid sequence LLGDLFGV, which corresponds to the amino acid positions 81 to 88 of the hdm2 proto-oncoprotein |
| 09/02/2004 | US20040170643 heat shock protein fused to a single epitope-containing segment comprising two or more identical epitopes and a DNA construct encoding it; reducing levels of a predetermined protein (e.g., hormone(s)) in an animal; vaccines |
| 09/02/2004 | US20040170630 Human monoclonal antibodies to heparanase |
| 09/02/2004 | US20040170627 Antagonists of Myelin-associated Glycoprotein and their use in the treatment and/or prevention of Neurological diseases |
| 09/02/2004 | US20040170624 active principle, especially the humanized monoclonal antibody JAQ1, that induces irreversible inactivation or degradation of the collagen receptor on thrombocytes; diagnostic agent for the determination of the expression rate of the collagen receptor GPVI |
| 09/02/2004 | CA2824150A1 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells |
| 09/02/2004 | CA2824126A1 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells |
| 09/02/2004 | CA2753408A1 Production of modified glycoproteins having multiple antennary structures |
| 09/02/2004 | CA2731504A1 Combinatorial dna library for producing modified n-glycans in lower eukaryotes |
| 09/02/2004 | CA2516550A1 Production of modified glycoproteins having multiple antennary structures |
| 09/02/2004 | CA2516544A1 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells |
| 09/02/2004 | CA2516527A1 Endomannosidases in the modification of glycoproteins in eukaryotes |
| 09/02/2004 | CA2516520A1 N-acetylglucosaminyltransferase iii expression in lower eukaryotes |
| 09/02/2004 | CA2516087A1 Antibodies against respiratory ailment-causing pathogens |
| 09/02/2004 | CA2514979A1 Antibody vaccine conjugates and uses therefor |
| 09/02/2004 | CA2511855A1 Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions |
| 09/01/2004 | EP1452600A1 Receptor and nucleic acid molecule encoding said receptor |
| 09/01/2004 | EP1452599A1 Improved epitope displaying phage |
| 09/01/2004 | EP1452597A1 Method of activating protein |
| 09/01/2004 | EP1452542A2 Reshaped human monoclonal antibodies specific for IgE |
| 09/01/2004 | EP1452541A1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof |
| 09/01/2004 | EP1451367A2 Engineering of leader peptides for the secretion of recombinant proteins in bacteria |
| 09/01/2004 | EP1451341A2 Eit-6, a polypeptide encoded by an estrogen regulated gene |
| 09/01/2004 | EP1451338A1 Recombinant antibodies for the detection and neutralization of anthrax toxin |
| 09/01/2004 | EP1451337A2 Nogo receptor-mediated blockade of axonal growth |
| 09/01/2004 | EP1451333A2 Ul16 binding protein 4 |
| 09/01/2004 | EP1451332A1 Production of eukaryotic proteins and nucleic acid molecules in c. elegans |
| 09/01/2004 | EP1451325A2 Transcription factor stress-related polypeptides and methods of use in plants |
| 09/01/2004 | EP1451322A2 Il-21 antagonists |
| 09/01/2004 | EP1451321A1 A method of genetic screening using an amplifiable gene |
| 09/01/2004 | EP1451315A2 Human coagulation factor vii polypeptides |
| 09/01/2004 | EP1451312A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/01/2004 | EP1451307A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/01/2004 | EP1451297A1 Phenotypic screen of chimeric proteins |
| 09/01/2004 | EP1451292A1 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted |
| 09/01/2004 | EP1451223A2 Expression control using variable intergenic sequences |
| 09/01/2004 | EP1451222A2 Novel proteins with il-6 inhibiting activity |
| 09/01/2004 | EP1451220A2 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases |
| 09/01/2004 | EP1451217A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides |
| 09/01/2004 | EP1451216A1 Immunointeractive molecules and uses thereof |
| 09/01/2004 | EP1451213A2 Human and murine cytokine polypeptides |
| 09/01/2004 | EP1451212A2 Structural and cytoskeleton-associated proteins |
| 09/01/2004 | EP1450960A1 Apparatus and method for modification of magnetically immobilized biomolecules |
| 09/01/2004 | EP1450857A2 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes |
| 09/01/2004 | EP1450847A2 Apo2 ligand/trail formulations |
| 09/01/2004 | EP1450828A2 In situ immunization |
| 09/01/2004 | EP1450752A2 Multivalent streptococcal vaccine compositions and methods for use |
| 09/01/2004 | EP0941369B1 Dna for evaluating the progression potential of cervical lesions |
| 09/01/2004 | EP0937139B1 Amidase |
| 09/01/2004 | EP0906336B1 Antibiotic producing microbe |
| 09/01/2004 | EP0772627B1 Production of biologically active recombinant neurotrophic protein |
| 09/01/2004 | EP0769057B1 RECOMBINANT MONO AND POLY ANTIGENS TO DETECT CYTOMEGALOVIRUS-SPECIFIC IgM IN HUMAN SERA BY ENZYME IMMUNOASSAY |
| 09/01/2004 | EP0767914B1 Antibodies to lipoproteins and apolipoproteins and methods of use thereof |
| 09/01/2004 | EP0764172B1 Synthetic peptide analogs of lung surfactant protein sp-c |
| 09/01/2004 | EP0728141B1 A method for identifying anti-parasitic compounds |
| 09/01/2004 | EP0634936B1 Methods for immunocontraception |
| 09/01/2004 | EP0616640B1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 09/01/2004 | EP0610254B1 Glial derived neurotrophic factor |
| 09/01/2004 | CN1526021A Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 09/01/2004 | CN1526011A Inhibition of apoptosis process and improvement of cell performance |
| 09/01/2004 | CN1526010A Bacterial host strains |
| 09/01/2004 | CN1525977A Purification of human serum albumin |
| 09/01/2004 | CN1525168A Methods of detecting alzheimer's disease |
| 09/01/2004 | CN1524963A Soybean oligopeptide production process and enzyme hydrolysis reaction kettle for realizing said process |
| 09/01/2004 | CN1524959A Method for producing gene engineering recombination 192 peptide human growth hormone |
| 09/01/2004 | CN1524957A Recombinant protein a gene ,its expression products and use |
| 09/01/2004 | CN1524950A Bacterial strain for preparing high efficiency capsule glycoprotein immunomodulator, screening and application thereof |
| 09/01/2004 | CN1524877A Construction and preparation of stroma cell derivative factor - 1ª‡ recombinant mutant |
| 09/01/2004 | CN1524575A Virulence genes and proteins, and their use |
| 09/01/2004 | CN1164762C Extraction method of chlorella growth factor (chlorella extract and CGF) |
| 09/01/2004 | CN1164761C Process for producing product contg. antihypertensive tripeptides |
| 09/01/2004 | CN1164755C Method of improving soluble expression of foreign gene in colon bacillus |
| 09/01/2004 | CN1164753C Fusion protein of type IV collagenase resistant single chain antibody and Lidamycin agon protein |
| 09/01/2004 | CN1164737C Preparing gamma-poly glutamic acid, glutamate, glutathione and its precursor with bacillus subtilis NX-2 |
| 09/01/2004 | CN1164616C Recombinant hepatitis B virus immune globulin |
| 08/31/2004 | US6784284 Polypeptide for use in treatment of bone and cell proliferation disorders |
| 08/31/2004 | US6783972 Methods for large-scale production of recombinant AAV vectors |
| 08/31/2004 | US6783960 Polypeptide for use in the treatment of thrombosis and sepsis |
| 08/31/2004 | US6783958 Generating biosensor protein; determine sequence of fluorescent protein, generate fusion protein, incubate with modulator, detect conformational adjustments, monitor adjustments in fluorescence |
| 08/31/2004 | US6783957 Comprises cell lysate/extract and continuously charging concentrations of magnesium, potassium, polyamines |
| 08/31/2004 | US6783956 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 08/31/2004 | US6783955 Polynucleotides encoding human presenilin variant |
| 08/31/2004 | US6783945 Cloning and uses of the genetic locus bcl-6 |
| 08/31/2004 | US6783760 Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 08/31/2004 | US6783758 Diagnosis and treatment of malignant neoplasms |
| 08/31/2004 | US6783751 Method for labeling biopolymers using isotopes |
| 08/31/2004 | CA2061362C Method for producing human nerve growth factor-2 |
| 08/26/2004 | WO2004072292A1 Method and device for the continuous production of biomolecules |